Medical Condition News

RSS
HPV-positive oropharyngeal cancer patients show longer survival pattern than those related to smoking

HPV-positive oropharyngeal cancer patients show longer survival pattern than those related to smoking

New smart phone app may help people detect epileptic seizures and treat stroke

New smart phone app may help people detect epileptic seizures and treat stroke

Reduction of RT to IB lymph nodes may result in better salivary function in head, neck cancer patients

Reduction of RT to IB lymph nodes may result in better salivary function in head, neck cancer patients

Lone star tick bites are likely the cause of severe red meat allergies

Lone star tick bites are likely the cause of severe red meat allergies

Anaphylaxis Campaign provides updated information on Idiopathic anaphylaxis

Anaphylaxis Campaign provides updated information on Idiopathic anaphylaxis

ACAAI experts suggest allergy sufferers to start taking medication before spring begins

ACAAI experts suggest allergy sufferers to start taking medication before spring begins

New 256-slice CT scanner to predict potential heart attack in one second

New 256-slice CT scanner to predict potential heart attack in one second

Study determines effectiveness of gabapentin for treatment of vulvodynia in women

Study determines effectiveness of gabapentin for treatment of vulvodynia in women

Study indicates relationship between multivitamin supplement use and cataract risk in men

Study indicates relationship between multivitamin supplement use and cataract risk in men

CEOi, New York Academy to launch Global Alzheimer's Platform to reduce time, costs of clinical trials

CEOi, New York Academy to launch Global Alzheimer's Platform to reduce time, costs of clinical trials

Epidemiological studies demonstrate that diseases of central nervous system protect against cancer

Epidemiological studies demonstrate that diseases of central nervous system protect against cancer

Ignyta reports preliminary results from ongoing Phase 1 clinical trial of RXDX-101

Ignyta reports preliminary results from ongoing Phase 1 clinical trial of RXDX-101

CSL Behring enrolls first patient in phase III study of C1-INH for prevention of HAE attacks

CSL Behring enrolls first patient in phase III study of C1-INH for prevention of HAE attacks

OrthoTrophix commences TPX-100 Phase 2 clinical study in knee osteoarthritis patients

OrthoTrophix commences TPX-100 Phase 2 clinical study in knee osteoarthritis patients

Study finds Cyclin A2 protein induces cardiac regeneration after myocardial infarction

Study finds Cyclin A2 protein induces cardiac regeneration after myocardial infarction

HPV-positive patients with OPSCC show higher overall survival rate than HPV-negative patients

HPV-positive patients with OPSCC show higher overall survival rate than HPV-negative patients

High-potency statins offer improved chance of survival in heart attack patients

High-potency statins offer improved chance of survival in heart attack patients

Researchers use cardiac monitor to assess atrial fibrillation after cryptogenic stroke

Researchers use cardiac monitor to assess atrial fibrillation after cryptogenic stroke

Survey finds inconsistency in inpatient psychiatry services for youth at hospitals across Ontario

Survey finds inconsistency in inpatient psychiatry services for youth at hospitals across Ontario

Researchers propose new treatment to prevent mucositis in cancer patients

Researchers propose new treatment to prevent mucositis in cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.